Previous 10 | Next 10 |
2023-09-28 05:30:00 ET All three major indexes have rallied since the start of the year, and we're getting closer and closer to a new bull market. That's great news for growth stocks because they are often the ones to benefit in an optimistic environment that favors expansion. In fact, many...
2023-09-27 11:35:01 ET More on CRISPR Therapeutics CRISPR Therapeutics: CEO Targets $25bn Valuation - Exa-Cel Approval Is First Step Crispr Therapeutics: The Chance To Load Up Is Finally Here (Technical Analysis) CRISPR Therapeutics AG (CRSP) Presents at Citi's 18th ...
ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced poster presentations of preclinical data at the Society for Immunotherapy o...
2023-09-20 17:14:28 ET Summary CRISPR Therapeutics has a partnership with Vertex over Exa-Cel, a potentially curative therapy for Sickle Cell Disease and beta thalassemia. The FDA will hold an Advisory Committee meeting before the December 8 decision on Exa-Cel's approval. CEO...
2023-09-20 07:21:00 ET CRISPR Therapeutics (NASDAQ: CRSP) and Bluebird Bio (NASDAQ: BLUE) are at the forefront of developing gene therapies, yet the shares of both companies have underperformed the market over the last 12 months. Still, the pair will likely soon be locked in...
2023-09-19 07:35:00 ET Other than running out of money, what economic risk do Intellia Therapeutics , (NASDAQ: NTLA) CRISPR Therapeutics , (NASDAQ: CRSP) Bluebird Bio , (NASDAQ: BLUE) and a bunch of other cutting-edge gene-editing biotechs have in common? There are a...
2023-09-16 09:21:00 ET CRISPR Therapeutics (NASDAQ: CRSP) is a healthcare company that makes gene-editing therapies that can transform the lives of patients. While it doesn't have an approved product today, that could change by the end of the year. The company has come a long wa...
2023-09-15 10:07:00 ET If you're a biotech investor, you've probably heard of both Recursion Pharmaceuticals (NASDAQ: RXRX) and CRISPR Therapeutics , (NASDAQ: CRSP) two of the most followed biotechs this year. Both companies could one day lead the sector thanks to their inno...
2023-09-15 05:49:00 ET Healthcare stocks, often considered recession-proof, have lagged most other sectors of the market so far this year. While the S&P 500 index is up by more than 16% and flirting with a return to bull market status, the healthcare sector is down by more than 2.5%...
2023-09-14 06:15:00 ET The market hasn't yet entered bull territory, but it's getting close. The S&P 500 already rose more than 20% from its bear market low -- now, it just has to reach a new high, and the next bull market will begin. Meanwhile, what can you do to prepare? You can p...
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
CRISPR Therapeutics AG Website: